Skip to main content

Detailed molecular comparison between the inhibition mode of A/B-type carboxypeptidases in the zymogen state and by the endogenous inhibitor latexin

Abstract.

Treatment of advanced stages of prostate carcinoma with histone-deacetylase inhibitors entails expression of human procarboxypeptidase-A4 (hPCPA4). The three-dimensional structure of hPCPA4 has been solved and shows the features of related metallocarboxypeptidase zymogens, with a preformed α/β/-hydrolase active-enzyme moiety (hCPA4) and an inhibiting pro-domain (PD). The protease moiety recalls a sphere, out of which a spherical cone has been cut. This results in a funnel-like structure, at the bottom of which the active-site cleft resides. The border of this funnel is shaped by loops, which are responsible for the interaction with the PD, characterised by a large interface area and relatively few contacts. Such an inhibitory mode is evocative of the recently reported structure of the human inhibitor latexin in its complex with hCPA4. The main contacting structure of latexin is similar to the one employed for PD inhibition. In both cases, active-site blocking relies mainly on a loop provided by the central part of a β sheet.

This is a preview of subscription content, access via your institution.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to J. Vendrell or F. X. Gomis-Rütha.

Additional information

R. Garcia-Castellanos and R. Bonet-Figueredo contributed equally to this study and share first authorship.

Received 28 April 2005; received after revision 1 June 2005; accepted 29 June 2005

Rights and permissions

Reprints and Permissions

About this article

Cite this article

García-Castellanos, R., Bonet-Figueredo, R., Pallarés, I. et al. Detailed molecular comparison between the inhibition mode of A/B-type carboxypeptidases in the zymogen state and by the endogenous inhibitor latexin. Cell. Mol. Life Sci. 62, 1996–2014 (2005). https://doi.org/10.1007/s00018-005-5174-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-005-5174-4

Key words.

  • Metallocarboxypeptidase
  • X-ray crystal structure
  • carboxypeptidase inhibitor
  • latexin